UNASSIGNED: The effect of SCBPE on cell proliferation and migration of HepG2 cells was evaluated based on MTT assay, morphology observation, or scratching assay. Furthermore, tandem mass tag-based quantitative proteomics was used to study the effect mechanisms. The mRNA expression levels of identified proteins were verified by RT-qPCR.
UNASSIGNED: Tandem mass tag-based quantitative proteomics showed that 61 differentially expressed proteins were obtained in the SCBPE group compared with the negative-control group: 18 significantly downregulated and 43 significantly upregulated proteins. Bioinformatic analysis showed the significantly enriched KEGG pathways were predominantly ferroptosis-, Wnt-, and hepatocellular carcinoma-signaling ones. Protein-protein interaction network analysis and RT-qPCR validation revealed SCBPE also downregulated the focal adhesion-signaling pathway, which is abrogated by PF-562271, a well-known inhibitor of FAK.
UNASSIGNED: This study confirmed SCBPE suppressed the cell proliferation and migration of hepatocellular carcinoma HepG2 cells, mainly through modulation of ferroptosis-, Wnt-, hepatocellular carcinoma-, and focal adhesion-signaling pathways, providing scientific data supporting adjuvant treatment of hepatocellular carcinoma using SCBP.
■基于MTT法评价SCBPE对HepG2细胞增殖和迁移的影响,形态学观察,或抓挠试验。此外,基于串联质量标签的定量蛋白质组学用于研究效应机制。通过RT-qPCR验证鉴定的蛋白质的mRNA表达水平。
■基于串联质量标签的定量蛋白质组学显示,与阴性对照组相比,SCBPE组获得了61种差异表达的蛋白质:18种显著下调,43种显著上调。生物信息学分析显示显著富集的KEGG途径主要是铁胞嘧啶-,Wnt-,和肝细胞癌信号。蛋白质-蛋白质相互作用网络分析和RT-qPCR验证显示,SCBPE也下调了粘着斑信号通路,由PF-562271废除,这是一种众所周知的FAK抑制剂。
■本研究证实SCBPE抑制肝癌HepG2细胞的增殖和迁移,主要通过铁胞嘧啶的调制,Wnt-,肝细胞癌-,和局灶性粘附信号通路,提供支持使用SCBP辅助治疗肝细胞癌的科学数据。